Asthma diagnosis and symptoms in an allergen immunotherapy trial treating grass pollen induced rhinoconjunctivitis

被引：0
|
作者：
Hviid-Vyff, Bjarke [1 ,2 ]
Schmid, Johannes Martin [1 ,2 ]
Hoffmann, Hans Jurgen [1 ,2 ]
机构：
[1] Aarhus Univ, Aarhus C, Denmark
[2] Aarhus Univ Hosp, Aarhus C, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA4749
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4749
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children with rhinoconjunctivitis
    Roder, E.
    Berger, M.
    Hop, W.
    de Groot, H.
    van Wijk, Gerth R.
    ALLERGY, 2012, 67 : 102 - 103
  • [22] Cost comparison of immunotherapy products for grass pollen induced rhinoconjunctivitis (hay fever) in the UK
    Vestenbaek, Ulrik
    CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (12): : 1880 - 1880
  • [23] Oralair®: sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis
    Hong, Jison
    Bielory, Leonard
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 437 - 444
  • [24] Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma
    Pfaar, Oliver
    Bachert, Claus
    Kuna, Piotr
    Panzner, Petr
    Dzupinova, Maria
    Klimek, Ludger
    van Nimwegen, Maroesja J.
    Boot, Johan D.
    Yu, Donghui
    Opstelten, Dirk Jan E.
    de Kam, Pieter-Jan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (03) : 970 - 977
  • [25] An evaluation of data on the relative clinical impact of sublingual allergen immunotherapy tablets and symptomatic medications in grass-pollen-induced allergic rhinoconjunctivitis
    Devillier, P.
    Dreyfus, J-F
    Demoly, P.
    Didier, A.
    de Beaumont, O.
    Calderon, M.
    ALLERGY, 2013, 68 : 71 - 71
  • [26] The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis
    Roder, Esther
    Berger, Marjolein Y.
    Hop, Wim C. J.
    de Groot, Hans
    van Wijk, Roy Gerth
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2013, 24 (01) : 39 - +
  • [27] Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial
    Walker, SM
    Pajno, GB
    Lima, MT
    Wilson, DR
    Durham, SR
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (01) : 87 - 93
  • [28] Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen-Induced Allergic Rhinoconjunctivitis
    Valovirta, Erkka
    Berstad, Aud Katrine Herland
    de Blic, Jacques
    Bufe, Albrecht
    Eng, Peter
    Halken, Susanne
    Ojeda, Pedro
    Roberts, Graham
    Tommerup, Lene
    Varga, Eva-Maria
    Winnergard, Inger
    CLINICAL THERAPEUTICS, 2011, 33 (10) : 1537 - 1546
  • [29] Safety and efficacy of 3-injection immunotherapy protocol for treating grass pollen-induced rhinoconjunctivitis in American adolescents/young adults
    Patterson, A.
    Bonney, A.
    Shiels, W., II
    Erwin, E.
    ALLERGY, 2015, 70 : 262 - 263
  • [30] Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis
    Dahl, R
    Stender, A
    Rak, S
    ALLERGY, 2006, 61 (02) : 185 - 190
12345